Nitin Roper

2.7k citations
44 papers · 1.2k indexed · h-index 16

Nitin Roper

42 papers receiving 1.2k citations

Peers

Nitin Roper
Comparison fields: 5 of 98
  • Oncology 421
  • Parasitology 84
  • Cancer Research 187
  • Pharmacology 84
  • Genetics 91
Replace Evelyn Zeindl‐Eberhart with:
Evelyn Zeindl‐Eberhart Germany
Shrihari S. Kadkol United States
Dongmei Yuan China
John F. Palma United States
Hideki Yokoo Japan
Peter Vuylsteke Belgium
David Demanse Switzerland
Lene Meldgaard Knudsen Denmark
Carsten Grüllich Germany
Anshu Marathe United States
Nitin Roper relative to Evelyn Zeindl‐Eberhart Germany Evelyn Zeindl‐Eberhart's profile →
Citations per field
00.5×6.2×
Evelyn Zeindl‐Eberhart · 1×
Citations per year

Countries citing papers authored by Nitin Roper

Since Specialization
Citations

This map shows the geographic impact of Nitin Roper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nitin Roper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nitin Roper more than expected).

Fields of papers citing papers by Nitin Roper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nitin Roper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nitin Roper. The network helps show where Nitin Roper may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Nitin Roper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nitin Roper Line = papers co-authored together Nitin Roper links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20241
2 20240
3 202311
4 20230
5 20226
6 202260
7 2021106
8 2021100
9 202092
10 20191
11 20191
12 20182
13 2017189
14 201623
15 201526
16 2014114
17 201136
18 20105
19 200846
20 199819

About Nitin Roper

Nitin Roper is a scholar working on Cancer Research, Oncology, Genetics, Pharmacology and Statistics, Probability and Uncertainty, having authored 44 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (8 papers), Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (8 papers), Cancer, Hypoxia, and Metabolism (7 papers), Adrenal and Paraganglionic Tumors (6 papers), Neuroendocrine Tumor Research Advances (4 papers), Ethics in Clinical Research (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Oncology (421 citations), Parasitology (84 citations), Cancer Research (187 citations), Pharmacology (84 citations) and Genetics (91 citations). Nitin Roper has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Kristian Stensland, Matthew D. Galsky, Anish Thomas, Yves Pommier, Suresh Kumar, Robert Bona, Simon J. Hall, Marc Pypaert, Derek Toomre and Juan P. Wisnivesky. Their work appears in journals such as Journal of Clinical Oncology, Cancers, Journal of Thoracic Oncology, Clinical Cancer Research and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026